What will you find at Conscio booth?

We will showcase a broad range of services that cover the entire pharmaceutical lifecycle:

  • Formulation development
  • Analytical R&D
  • GMP manufacturing of IMPs
  • Clinical trials and bioanalytical testing
  • Quality control of small molecules and biologics
  • Post-approval and regulatory support

We will be happy to discuss your projects over a freshly prepared coffee or artisan tea.

You will also have the opportunity to meet our strategic partner and trusted representative in the USA – Kiel Laboratories, specialists in bringing new drugs to market, particularly through the 505(b)(2) pathway for FDA approval. We are pleased to welcome them at our booth again.

If you’re interested in arranging a meeting with us, please reach out to your business representative or send an email to sales@quinta.cz, and we will schedule a time slot for you.

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

ALL POSTS